Most Active Volume Stock: Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) gained 13.39 Percent and closed its previous trading session at $0.33. The stock traded with the average Volume of 1.5 Million at the end of last session.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) has the Market Capitalization of 23.29 Million. The Stock has its 52-week High of $2.980 and 52-Week Low of $0.210 and it touched its 52-week high on 10/03/17 and 52-Week Low on 07/18/18


The company reported its last earnings Actual EPS of $-0.29/share. While, the analyst predicted that the company could provide an EPS of $-0.25/share. Hence the difference between Predicted EPS and Actual EPS reported is $-0.04/share which shows an Earnings Surprise of -16 Percent.

Sell side analysts plays vital role in buying and selling a stock where 0 analysts rated Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) as Buy, 1 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 11.69% where SMA50 and SMA200 are -4.18% and -72.19% respectively.

The company shows its Return on Assets (ROA) value of -24.8%. The Return on Equity (ROE) value stands at -329.1%. While it’s Return on Investment (ROI) value is -31.1%.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) currently has a Weekly Volatility of 15.99% percent while its Monthly Volatility is at 17.87% percent. While talking about Performance of the Stock, Aralez Pharmaceuticals Inc. currently has a Weekly performance of 15.58%, monthly performance percentage is 8.75 percent, Quarterly performance is -23.91 percent, 6 months performance shows a percent value of -80.09% and Yearly Performance is -70.13 percent.

Company Profile:

Aralez Pharmaceuticals Inc. is a global specialty pharmaceutical company. They acquire, develop and commercialize products primarily in cardiovascular, pain and other specialty areas.